REMOTE PATIENT MONITORING ANALYTICS
A dashboard should distinguish a patient trend from a broken feed. We build RPM analytics that make data freshness, measurement quality and cohort context visible—so care teams and program operators can investigate the right issue.
Find the gaps in your RPM dataFor RPM platforms, care-management organizations and provider analytics teams with monitoring data but limited confidence in the signals it produces.
Identity, units and timestamps
Freshness and quality checks
Cohorts and approved rules
Review queues and ownership
Illustrative workflow · scope tailored to your environment
Start with the real problem
An empty chart may mean no measurement, failed transmission, an unassigned device or a delayed integration. A lower average may reflect a changed cohort rather than a patient improvement. We design the analytical model around these distinctions, so a team can see the source, denominator and limitations behind a result instead of relying on an unexplained score.
Your starting point
Distinguish expected measurements from received, rejected and late records. Show whether an issue belongs to patient outreach, device support or the integration team.
Compare enrollment groups, sites or periods using explicit inclusion rules. Preserve changes in the cohort definition and make missingness visible alongside aggregate trends.
Turn approved rules into reviewable signals with measurement context and source links. Track acknowledgment and disposition while separating analytical signals from clinical conclusions.
The Engineering Engagement
Workstreams are selected around your priorities. Each comes with an output your team can inspect, test and own.
Normalize units, observation type, patient-device association and event timestamps. Preserve original values and vendor metadata so transformations can be inspected later.
Detect duplicates, delayed arrivals, invalid formats and unexpected gaps. Keep technical rejection separate from a clinically unusual but valid measurement.
Document inclusion, exclusion, time windows and denominator changes. Distinguish active enrollment, data availability and program participation rather than treating them as one population.
Implement clinically approved review criteria with supporting context, routing and acknowledgment. Provide a visible path for false positives, unresolved items and unavailable reviewers.
Build the agreed warehouse or lakehouse models with lineage, restricted access and de-identified development fixtures. Keep patient-level drilldown permissions separate from aggregate reporting.
Expertise is in the decisions
First identify whether the unreliable signal comes from ingestion, identity, measurement quality or the analysis itself. A new visualization will not fix an incorrect denominator.
An operational feed-health queue and a monthly program report have different latency requirements. Agree freshness targets and show the last successful update explicitly.
Program populations, device types and observation windows can differ. We expose those differences and avoid implying causal improvement from an uncontrolled dashboard comparison.
Clinical thresholds, review urgency and interventions require approval by qualified clinical owners. An analytical flag should not silently become a diagnosis or treatment instruction.
We can connect the sources you need, but device provisioning, firmware behavior and vendor feed access are distinct dependencies. The analytics layer cannot recover measurements never recorded upstream.
If a predictive model is in scope, define its intended use, evaluation population, limitations and monitoring plan. We do not label an unvalidated score as an early-warning capability.
From discussion to delivery
Inspect de-identified sample records, feed timing, device assignments and existing dashboard definitions.
Validate units, event time, duplicate behavior and representative missing-data scenarios.
Build a priority cohort or review queue and trace every displayed result back to its sources.
Hand over freshness monitoring, metric-change review and procedures for investigating unreliable signals.
We agree the scope, dependencies, acceptance criteria and commercial model before implementation. Your existing team can stay involved throughout.
Find the right starting point ↗No. Device integration makes records available; analytics makes their meaning, quality and limitations usable. We can scope both, but they have different acceptance tests.
Yes. We review the warehouse or lakehouse, orchestration, access controls and data contracts before recommending a new platform.
We can evaluate a bounded use case after checking data suitability and clinical governance. Validation and monitoring are separate deliverables, not assumptions hidden inside dashboard development.
Each priority metric should have an owner, definition, source mapping and reproducible test set. Users should be able to see freshness and important limitations at the point of use.
A useful first conversation
Tell us what exists today, who uses it and where the workflow breaks. We’ll discuss the scope, access dependencies and the next practical step.
A product overview and a de-identified workflow are enough to start. No patient records or credentials are needed.
These are independent reference sources, not endorsements. Applicability, platform access and current requirements are confirmed for your project.
